Insider · CIK 0001867899
Eben Tessari
cooofficer
Files at KNSA (Kiniksa Pharmaceuticals International, plc). First filing Oct 17, 2024, latest Dec 17, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 21
$0 bought, $19M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
KNSA: Kiniksa Pharmaceuticals International, plc
KNSAOct 9, 2026 · close 79.78
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 28Weak | Kiniksa Pharmaceuticals International, plc | $501k 12,048 shares | -42% | +129% from low-3% from high | |
| 0Weak | Kiniksa Pharmaceuticals International, plc | $8,578 200 shares | -1% | +134% from low-0% from high | |
| 21Weak | Kiniksa Pharmaceuticals International, plc | $514k 12,470 shares | -35% | +128% from low0% from high | |
| 27Weak | Kiniksa Pharmaceuticals International, plc | $466k 12,368 shares | -30% | +109% from low-2% from high | |
| 30Weak | Kiniksa Pharmaceuticals International, plc | $1.6M 42,000 shares | -55% | +113% from low0% from high | |
| 29Weak | Kiniksa Pharmaceuticals International, plc | $598k 16,400 shares | -32% | +101% from low-1% from high | |
| 45Moderate | Kiniksa Pharmaceuticals International, plc | $3.5M 98,660 shares | -76% | +95% from low0% from high | |
| 29Weak | Kiniksa Pharmaceuticals International, plc | $536k 15,091 shares | -25% | +95% from low0% from high | |
| 29Weak | Kiniksa Pharmaceuticals International, plc | $547k 16,200 shares | -29% | +86% from low0% from high | |
| 45Moderate | Kiniksa Pharmaceuticals International, plc | $4.6M 138,614 shares | -74% | +82% from low0% from high | |
| 14Weak | Kiniksa Pharmaceuticals International, plc | $543k 18,900 shares | -28% | +59% from low-5% from high | |
| 23Weak | Kiniksa Pharmaceuticals International, plc | $489k 17,300 shares | -22% | +56% from low-6% from high | |
| 45Moderate | Kiniksa Pharmaceuticals International, plc | $2.2M 70,867 shares | -86% | +67% from low0% from high | |
| 19Weak | Kiniksa Pharmaceuticals International, plc | $317k 12,000 shares | -14% | +47% from low-4% from high | |
| 11Weak | Kiniksa Pharmaceuticals International, plc | $246k 12,000 shares | -13% | +14% from low-25% from high | |
| 18Weak | Kiniksa Pharmaceuticals International, plc | $261k 12,409 shares | -14% | - | |
| 3Weak | Kiniksa Pharmaceuticals International, plc | $274k 14,000 shares | -15% | - | |
| 3Weak | Kiniksa Pharmaceuticals International, plc | $255k 14,000 shares | -14% | - | |
| 15Weak | Kiniksa Pharmaceuticals International, plc | $470k 23,017 shares | -19% | - | |
| 20Weak | Kiniksa Pharmaceuticals International, plc | $358k 17,000 shares | -14% | - | |
| 7Weak | Kiniksa Pharmaceuticals International, plc | $457k 17,000 shares | -13% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +6,000 | $8.83 | $53k | 28,714 | Dec 17, 2025 |
| Dec 15, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -12,048 | $41.56 | $501k | 16,666 | Dec 17, 2025 |
| Dec 15, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -6,000 | $0.00 | $0 | 0 | Dec 17, 2025 |
| Nov 26, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +200 | $22.89 | $4,578 | 22,914 | Dec 1, 2025 |
| Nov 26, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -200 | $42.89 | $8,578 | 22,714 | Dec 1, 2025 |
| Nov 26, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -200 | $0.00 | $0 | 46,938 | Dec 1, 2025 |
| Nov 17, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +6,500 | $8.83 | $57k | 35,184 | Nov 19, 2025 |
| Nov 17, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -645 | $40.08 | $26k | 34,539 | Nov 19, 2025 |
| Nov 17, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -11,825 | $41.30 | $488k | 22,714 | Nov 19, 2025 |
| Nov 17, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -6,500 | $0.00 | $0 | 6,000 | Nov 19, 2025 |
| Oct 14, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +6,500 | $8.83 | $57k | 41,052 | Oct 16, 2025 |
| Oct 14, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -11,815 | $37.65 | $445k | 29,237 | Oct 16, 2025 |
| Oct 14, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -553 | $37.99 | $21k | 28,684 | Oct 16, 2025 |
| Oct 14, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -6,500 | $0.00 | $0 | 12,500 | Oct 16, 2025 |
| Sep 29, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +42,000 | $17.92 | $753k | 76,552 | Oct 1, 2025 |
| Sep 29, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -42,000 | $38.33 | $1.6M | 34,552 | Oct 1, 2025 |
| Sep 29, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -42,000 | $0.00 | $0 | 0 | Oct 1, 2025 |
| Sep 15, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +6,500 | $8.83 | $57k | 50,952 | Sep 17, 2025 |
| Sep 15, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -16,044 | $36.45 | $585k | 34,908 | Sep 17, 2025 |
| Sep 15, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -356 | $37.00 | $13k | 34,552 | Sep 17, 2025 |
| Sep 15, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -6,500 | $0.00 | $0 | 19,000 | Sep 17, 2025 |
| Sep 4, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +38,725 | $15.50 | $600k | 83,177 | Sep 8, 2025 |
| Sep 4, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +46,546 | $15.52 | $722k | 129,723 | Sep 8, 2025 |
| Sep 4, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -85,271 | $35.52 | $3.0M | 44,452 | Sep 8, 2025 |
| Sep 5, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +13,389 | $15.52 | $208k | 57,841 | Sep 8, 2025 |
| Sep 5, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -13,389 | $35.66 | $477k | 44,452 | Sep 8, 2025 |
| Sep 4, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -38,725 | $0.00 | $0 | 6,249 | Sep 8, 2025 |
| Sep 4, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -46,546 | $0.00 | $0 | 13,389 | Sep 8, 2025 |
| Sep 5, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -13,389 | $0.00 | $0 | 0 | Sep 8, 2025 |
| Sep 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +1,746 | - | - | 41,961 | Sep 3, 2025 |
| Sep 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +1,773 | - | - | 43,734 | Sep 3, 2025 |
| Sep 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +2,726 | - | - | 46,460 | Sep 3, 2025 |
| Sep 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | FTax withholding Class A Ordinary Share10b5-1 | -3,022 | $33.49 | $101k | 43,438 | Sep 3, 2025 |
| Sep 2, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +1,964 | - | - | 45,402 | Sep 3, 2025 |
| Sep 2, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | FTax withholding Class A Ordinary Share10b5-1 | -950 | $34.28 | $33k | 44,452 | Sep 3, 2025 |
| Sep 3, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +65 | $15.52 | $1,009 | 44,517 | Sep 3, 2025 |
| Sep 3, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +15,026 | $15.50 | $233k | 59,543 | Sep 3, 2025 |
| Sep 3, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -15,091 | $35.50 | $536k | 44,452 | Sep 3, 2025 |
| Sep 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | AGrant or award Restricted Share Unitderivative10b5-1 | +9,828 | $0.00 | $0 | 9,828 | Sep 3, 2025 |
| Sep 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | AGrant or award Share Optionderivative10b5-1 | +39,364 | $0.00 | $0 | 39,364 | Sep 3, 2025 |
| Sep 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Restricted Share Unitderivative10b5-1 | +1,746 | $0.00 | $0 | 5,235 | Sep 3, 2025 |
| Sep 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Restricted Share Unitderivative10b5-1 | -1,773 | $0.00 | $0 | 3,545 | Sep 3, 2025 |
| Sep 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Restricted Share Unitderivative10b5-1 | -2,726 | $0.00 | $0 | 2,726 | Sep 3, 2025 |
| Sep 2, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Restricted Share Unitderivative10b5-1 | -1,964 | $0.00 | $0 | 0 | Sep 3, 2025 |
| Sep 3, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -65 | $0.00 | $0 | 59,935 | Sep 3, 2025 |
| Sep 3, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -15,026 | $0.00 | $0 | 44,974 | Sep 3, 2025 |
| Aug 18, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +6,500 | $8.83 | $57k | 56,415 | Aug 20, 2025 |
| Aug 18, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -16,100 | $33.77 | $544k | 40,315 | Aug 20, 2025 |
| Aug 18, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -100 | $34.44 | $3,444 | 40,215 | Aug 20, 2025 |
| Aug 18, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -6,500 | $0.00 | $0 | 25,500 | Aug 20, 2025 |
| Jul 15, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | AGrant or award Class A Ordinary Share10b5-1 | +752 | $15.63 | $12k | 49,915 | Aug 7, 2025 |
| Aug 5, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +38,928 | $10.36 | $403k | 88,843 | Aug 7, 2025 |
| Aug 5, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +30,444 | $12.97 | $395k | 119,287 | Aug 7, 2025 |
| Aug 5, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +32,710 | $11.10 | $363k | 151,997 | Aug 7, 2025 |
| Aug 5, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +25,896 | $11.97 | $310k | 177,893 | Aug 7, 2025 |
| Aug 5, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +10,636 | $10.76 | $114k | 188,529 | Aug 7, 2025 |
| Aug 5, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -138,064 | $33.20 | $4.6M | 50,465 | Aug 7, 2025 |
| Aug 5, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -550 | $33.90 | $19k | 49,915 | Aug 7, 2025 |
| Aug 5, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -38,928 | $0.00 | $0 | 0 | Aug 7, 2025 |
| Aug 5, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -30,444 | $0.00 | $0 | 16,694 | Aug 7, 2025 |
| Aug 5, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -32,710 | $0.00 | $0 | 32,710 | Aug 7, 2025 |
| Aug 5, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -25,896 | $0.00 | $0 | 39,524 | Aug 7, 2025 |
| Aug 5, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -10,636 | $0.00 | $0 | 31,908 | Aug 7, 2025 |
| Jul 14, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +6,500 | $8.83 | $57k | 68,063 | Jul 16, 2025 |
| Jul 14, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -18,900 | $28.72 | $543k | 49,163 | Jul 16, 2025 |
| Jul 14, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -6,500 | $0.00 | $0 | 32,000 | Jul 16, 2025 |
| Jun 16, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +6,500 | $8.83 | $57k | 78,863 | Jun 18, 2025 |
| Jun 16, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -17,300 | $28.28 | $489k | 61,563 | Jun 18, 2025 |
| Jun 16, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -6,500 | $0.00 | $0 | 38,500 | Jun 18, 2025 |
| Jun 9, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +10,319 | $10.36 | $107k | 82,682 | Jun 11, 2025 |
| Jun 9, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -10,319 | $30.38 | $313k | 72,363 | Jun 11, 2025 |
| Jun 10, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +15,506 | $10.36 | $161k | 87,869 | Jun 11, 2025 |
| Jun 10, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -15,506 | $30.46 | $472k | 72,363 | Jun 11, 2025 |
| Jun 11, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +45,042 | $10.36 | $467k | 117,405 | Jun 11, 2025 |
| Jun 11, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -45,042 | $30.51 | $1.4M | 72,363 | Jun 11, 2025 |
| Jun 9, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -10,319 | $0.00 | $0 | 99,476 | Jun 11, 2025 |
| Jun 10, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -15,506 | $0.00 | $0 | 83,970 | Jun 11, 2025 |
| Jun 11, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -45,042 | $0.00 | $0 | 38,928 | Jun 11, 2025 |
| May 19, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +7,000 | $3.80 | $27k | 84,363 | May 21, 2025 |
| May 19, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -12,000 | $26.41 | $317k | 72,363 | May 21, 2025 |
| May 19, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -7,000 | $0.00 | $0 | 49 | May 21, 2025 |
| May 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | AGrant or award Performance Share Unitderivative | +4,975 | $0.00 | $0 | 4,975 | May 5, 2025 |
| May 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | AGrant or award Performance Share Unitderivative | +5,224 | $0.00 | $0 | 5,224 | May 5, 2025 |
| May 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | AGrant or award Performance Share Optionderivative | +8,042 | $0.00 | $0 | 8,042 | May 5, 2025 |
| May 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | AGrant or award Performance Share Optionderivative | +8,302 | $0.00 | $0 | 8,302 | May 5, 2025 |
| Apr 14, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +7,000 | $3.80 | $27k | 89,363 | Apr 16, 2025 |
| Apr 14, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -5,579 | $20.19 | $113k | 83,784 | Apr 16, 2025 |
| Apr 14, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -6,421 | $20.74 | $133k | 77,363 | Apr 16, 2025 |
| Apr 14, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -7,000 | $0.00 | $0 | 7,049 | Apr 16, 2025 |
| Apr 7, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share | +2,726 | - | - | 83,164 | Apr 9, 2025 |
| Apr 7, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | FTax withholding Class A Ordinary Share | -801 | $20.28 | $16k | 82,363 | Apr 9, 2025 |
| Apr 7, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Restricted Share Unitderivative | -2,726 | $0.00 | $0 | 2,726 | Apr 9, 2025 |
| Apr 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share | +1,773 | - | - | 79,726 | Apr 3, 2025 |
| Apr 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share | +1,746 | - | - | 81,472 | Apr 3, 2025 |
| Apr 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | FTax withholding Class A Ordinary Share | -521 | $21.77 | $11k | 80,951 | Apr 3, 2025 |
| Apr 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | FTax withholding Class A Ordinary Share | -513 | $21.77 | $11k | 80,438 | Apr 3, 2025 |
| Apr 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | AGrant or award Share Optionderivative | +39,364 | $0.00 | $0 | 39,364 | Apr 3, 2025 |
| Apr 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | AGrant or award Restricted Share Unitderivative | +9,828 | $0.00 | $0 | 9,828 | Apr 3, 2025 |
| Apr 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | AGrant or award Performance Share Unitderivative | +19,657 | $0.00 | $0 | 19,657 | Apr 3, 2025 |
| Apr 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Restricted Share Unitderivative | -1,773 | $0.00 | $0 | 3,545 | Apr 3, 2025 |
| Apr 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Restricted Share Unitderivative | -1,746 | $0.00 | $0 | 5,235 | Apr 3, 2025 |
| Mar 16, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share | +1,964 | - | - | 78,530 | Mar 19, 2025 |
| Mar 16, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | FTax withholding Class A Ordinary Share | -577 | $22.61 | $13k | 77,953 | Mar 19, 2025 |
| Mar 16, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Restricted Share Unitderivative | -1,964 | $0.00 | $0 | 0 | Mar 19, 2025 |
| Mar 10, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +7,000 | $3.80 | $27k | 88,975 | Mar 12, 2025 |
| Mar 10, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -12,409 | $21.06 | $261k | 76,566 | Mar 12, 2025 |
| Mar 10, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -7,000 | $0.00 | $0 | 14,049 | Mar 12, 2025 |
| Feb 10, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +7,000 | $3.80 | $27k | 95,975 | Feb 12, 2025 |
| Feb 10, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -14,000 | $19.57 | $274k | 81,975 | Feb 12, 2025 |
| Feb 10, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -7,000 | $0.00 | $0 | 21,049 | Feb 12, 2025 |
| Jan 13, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +7,000 | $3.80 | $27k | 102,975 | Jan 15, 2025 |
| Jan 13, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -12,323 | $18.13 | $223k | 90,652 | Jan 15, 2025 |
| Jan 13, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -1,677 | $19.08 | $32k | 88,975 | Jan 15, 2025 |
| Jan 13, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -7,000 | $0.00 | $0 | 28,049 | Jan 15, 2025 |
| Dec 16, 2024 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +16,017 | $1.59 | $25k | 118,992 | Dec 18, 2024 |
| Dec 16, 2024 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -23,017 | $20.44 | $470k | 95,975 | Dec 18, 2024 |
| Dec 16, 2024 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -16,017 | $0.00 | $0 | 0 | Dec 18, 2024 |
| Nov 18, 2024 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +10,000 | $1.59 | $16k | 119,975 | Nov 20, 2024 |
| Nov 18, 2024 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -17,000 | $21.04 | $358k | 102,975 | Nov 20, 2024 |
| Nov 18, 2024 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -10,000 | $0.00 | $0 | 16,017 | Nov 20, 2024 |
| Oct 15, 2024 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +10,000 | $1.59 | $16k | 126,975 | Oct 17, 2024 |
| Oct 15, 2024 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -17,000 | $26.87 | $457k | 109,975 | Oct 17, 2024 |
| Oct 15, 2024 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -10,000 | $0.00 | $0 | 26,017 | Oct 17, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.